News
The results of the phase 1 study open-label trial showed the therapy was safe, raising the possibility of a more effective and more appealing treatment for the…
Webinar AL Amyloidosis
On October 26, 2021 the first ever World Amyloidosis Day will be organized by Amyloidosis Alliance and patient organisations from 18…
This year's event is dedicated to the passionate and growing community of amyloid patients, care providers, researchers and clinicians both locally and around the…
The Foundation for Peripheral Neuropathy (FPN) invites you to join us for a discussion on Hereditary Neuropathy and Genetic Testing. Brett McCray, M.D., PhD, will…
The Veterans Health Administration exists to integrate health care services for those who served in the U.S. Armed Forces. Yet for many veterans, getting access to…
Amyloidosis Support Groupsexternal link, opens in a new tab invite you to join Monica Fawzy Bryant Esq from Triage Cancer as she explains:
What You Need to Know…
ATTR amyloidosis is a frequently unrecognized but increasingly important cause of cardiomyopathy and neuropathy. While relatively uncommon compared to other…
This program is intended for people interested in learning about hATTR amyloidosis, including individuals diagnosed with hATTR amyloidosis, their families, and…
This program is intended for people interested in learning about hATTR amyloidosis, including individuals diagnosed with hATTR amyloidosis, their families, and…
This program is intended for people interested in learning about hATTR amyloidosis, including individuals diagnosed with hATTR amyloidosis, their families, and…